J&J strikes Alzheimer's research deal with Swiss firm AC Immune

J&J strikes Alzheimer's research deal with Swiss firm AC Immune

LONDON/ZURICH (Reuters) – Johnson & Johnson boosted its research efforts into battling Alzheimer's on Monday, striking a deal potentially worth more than $500 million to develop anti-tau vaccines with Swiss biotech firm AC Immune. Tau is a protein …

10
Like
Save

Comments

Write a comment

*